InhalationThe combination preparation ipratropium/salbutamol is a formulation containing using combivent and spiriva together bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered using combivent and spiriva together inhaler (MDI) and.

pulmonary disease (COPD) and asthma. It is marketed by using combivent and spiriva together using combivent and spiriva together as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent.[hide]v using combivent and spiriva together d • eDrugs for obstructive airway diseases: asthma/COPD (R03)Adrenergics, inhalants Short acting ?2-agonists: Salbutamol/Levosalbutamol • Fenoterol • using combivent and spiriva together acting ?2-agonists (LABA): Bambuterol • Clenbuterol • using combivent and spiriva together • Salmeterolother: Epinephrine • Isoproterenol • OrciprenalineGlucocorticoids Beclometasone • Budesonide • Ciclesonide • Fluticasone • MometasoneAnticholinergics Ipratropium • TiotropiumMast cell stabilizers Cromoglicate • NedocromilXanthines Aminophylline • Theobromine • TheophyllineLeukotriene antagonists Montelukast • Pranlukast • ZafirlukastCombination products Budesonide/formoterol • Fluticasone/salmeterol • Ipratropium/salbutamolThis pharmacology-related article is a stub. using combivent and spiriva together can help Wikipedia by expanding it.Retrieved from.

number ?ATC code ?PubChem ?Therapeutic considerationsPregnancy cat. ?Legal statusRoutes.